Trial Watch: Adoptive cell transfer for anticancer immunotherapy.
about
Trial Watch: Adoptive cell transfer for oncological indicationsTrial Watch: Immunomodulatory monoclonal antibodies for oncological indicationsTrial Watch: Immunogenic cell death inducers for anticancer chemotherapyTrial Watch:: Oncolytic viruses for cancer therapyTrial watch: Dendritic cell-based anticancer therapyImproving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer VaccinationTrial Watch-Oncolytic viruses and cancer therapyTrial Watch-Immunostimulation with cytokines in cancer therapyTrial Watch: Proteasomal inhibitors for anticancer therapyManufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapiesStem memory T cells (TSCM)-their role in cancer and HIV immunotherapiesNovel immune checkpoint blocker approved for the treatment of advanced melanomaTrial Watch: Therapeutic vaccines in metastatic renal cell carcinomaDesigned ankyrin repeat proteins are effective targeting elements for chimeric antigen receptors.Doubling the blockade for melanoma immunotherapyChimeric antigen receptor-engineered T cells as oncolytic virus carriers.T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice.Trial Watch: Immunotherapy plus radiation therapy for oncological indications.A Primer for Oncoimmunology (Immunooncology).Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma.T cell therapies-are T memory stem cells the answer?Combinatorial immunotherapy with checkpoint blockers solves the problem of metastatic melanoma-An exclamation sign with a question mark.Immunotherapy of hematological cancers: PD-1 blockade for the treatment of Hodgkin's lymphoma.Improvement in diagnostic and therapeutic arthrocentesis via constant compression.
P2860
Q26785545-ADF2A88D-806A-4607-AA1C-9C25077A4507Q26996518-04C59AAD-42C4-46B9-99E2-BA1D467BC9C3Q27004011-1B4A9AF1-668A-402C-BA40-54B88BC1B76AQ27021951-C28F7AA8-6FB8-44CE-9D5D-96C6EFEFA286Q27024047-0B5FF726-A90D-4759-B8A2-C3151B06854BQ28068378-252163C6-50FF-4624-9B53-E9318FD16394Q28072347-8939BC96-B576-4463-A8A5-90A7E807528EQ28078725-ADA0E3FB-A74C-408E-ADAE-562FABAAA1FEQ28082910-222E7DD9-BEA8-4FD6-827E-A696B7AE0FB3Q28085769-AB2E1D9A-9CFF-4FD6-81AE-3283447F0B00Q34511615-95F69A95-A82F-48BC-B1DC-B054B65FDB0AQ34936394-C0377AE8-74F8-4D37-A732-353968C6564FQ35799377-E35B18F7-BDA9-4884-AA8E-D3BD2D089DC0Q36370414-C8080B47-E930-4A52-B17F-9BE040F8765DQ36597356-4A9CB179-E8E6-496C-9F2A-A3EB4018354FQ36664258-DD722D9F-20E7-4760-9C3D-2245199670D1Q36757142-E1535CB0-93F9-4914-B526-21BD1C1B6CFFQ37308207-BAB2DBED-43B2-41B7-8ACA-5AA27DFD8B86Q39387761-D30B1E49-0431-4C2F-BD78-D302692D3E4EQ40438006-A7A59A0C-B689-4E20-9872-D838A0ED439DQ40895848-81B39B7A-D7EE-4ABD-A80A-9806B86E7786Q41591613-41D2156E-FAA9-472A-A007-390065AB5725Q41592435-6AF606DA-8216-48A5-9C2C-DE08BD826428Q50075614-51F1A9A9-30E3-4DB3-A312-2EE0D0975B9D
P2860
Trial Watch: Adoptive cell transfer for anticancer immunotherapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Trial Watch: Adoptive cell transfer for anticancer immunotherapy.
@en
Trial Watch: Adoptive cell transfer for anticancer immunotherapy.
@nl
type
label
Trial Watch: Adoptive cell transfer for anticancer immunotherapy.
@en
Trial Watch: Adoptive cell transfer for anticancer immunotherapy.
@nl
prefLabel
Trial Watch: Adoptive cell transfer for anticancer immunotherapy.
@en
Trial Watch: Adoptive cell transfer for anticancer immunotherapy.
@nl
P2860
P50
P356
P1433
P1476
Trial Watch: Adoptive cell transfer for anticancer immunotherapy.
@en
P2093
Alexander Eggermont
Florine Obrist
P2860
P304
P356
10.4161/ONCI.28344
P50
P577
2014-05-01T00:00:00Z